Nebuliser therapy in childhood

Thorax

Volumn 52, Issue SUPPL. 2, 1997, Pages

  Barry, Peter W ^a   O'Callaghan, Christopher ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOPHYLLINE; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; HYDROCORTISONE; IPRATROPIUM BROMIDE; MEASLES VACCINE; PREDNISOLONE; RIBAVIRIN; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE;

ARTIFICIAL VENTILATION; ASTHMA; ASTHMATIC STATE; BRONCHIOLITIS; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CROUP; CYSTIC FIBROSIS; HOME CARE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MEASLES; MEDICAL NEBULIZER; META ANALYSIS; METERED DOSE INHALER; NEBULIZATION; NEWBORN INTENSIVE CARE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030982727     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.2008.s78     Document Type: Review

References (127)

1. Everard ML, Hardy JG, Milner AD. Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation. Thorax 1993;48:1045-6.
2. Pedersen S, Ostergaard PA. Nasal inhalation as a cause of inefficient pulmonal aerosol inhalation technique in children. Allergy 1983;38:191-4.
3. Ryan G, Dolovich MB, Eng P, Obminski G, Cockroft DW, Juniper E, et al. Standardisation of inhalation provocation tests: influence of nebuliser output, particle size and method of inhalation. J Allergy Clin Immunol 1981;67: 156-61.
4. Cardellicchio S, Ferrante E, Castellani W, Panuccio B, Comis G, Boddi V. Influence of inspiratory flow rate on the bronchial response to ultrasonic mist of distilled water in asthmatic patients. Respiration 1989;56:220-6.
5. Newman SP, Clark AR, Talaee N, Clarke SW. Lung deposition of 5 mg Intal from a pressurised metered dose inhaler assessed by radiotracer technique. Int J Pharm 1991;74:203-8.
6. Collis GG, Cole CH, Le Souef PN. Dilution of nebulised aerosols by air entrainment in children. Lancet 1990;336: 341-3.
7. Le Souef PN. Validity of methods used to test airway responsiveness in children. Lancet 1992;339:1282-4.
8. Stick SM, Turnbull S, Chua HL, Landau LI, Le Souef PN. Bronchial responsiveness to histamine in infants and older children. Am Rev Respir Dis 1990;142:1143-6.
9. Salmon B, Wilson NM, Silverman M. How much aerosol reaches the lungs of wheezy infants and toddlers? Arch Dis Child 1990;65:401-3.
10. Chung KF, Jeyasingh K, Snashall PD. Influence of airway calibre on the intrapulmonary dose and distribution of inhaled aerosol in normal and asthmatic subjects. Eur Respir J 1988;1:890-5.
11. Love RG, Muir DCF. Aerosol deposition and airway obstruction. Am Rev Respir Dis 1976;114:891-7.
12. Alderson PO, Secker-Walker RH, Strominger DB, Markham J, Hill RL. Pulmonary deposition of aerosols in children with cystic fibrosis. J Pediatr 1974;84:479-84.
13. O'Doherty MJ, Thomas SHL, Gibb D, Page CJ, Harrington C, Duggan C, et al. Lung deposition of nebulised pentamidine in children. Thorax 1993;48:220-6.
14. Mukhopadhyay S, Staddon GE, Eastman C, Palmer M, Rhys-Davies E, Carswell F. The quantitative distribution of nebulised antibiotic in the lung in cystic fibrosis. Respir Med 1994;88:203-11.
15. Chua HL, Collis GG, Newbury AM, Chan K, Bower GD, Sly PD, et al. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994;7: 2185-91.
16. O'Callaghan C. Particle size of beclomethasone dipropionate produced by two nebulisers and two spacing devices. Thorax 1990;45:109-11.
17. Henderson AJ, Young S, Stick SM, Landau LI, LeSouef PN. Effect of salbutamol on histamine induced bronchoconstriction in healthy infants. Thorax 1993;48:317-23.
18. O'Callaghan C, Milner AD, Webb MSC, Swarbrick A. Nebulised water as a bronchoconstricting challenge in infancy. Arch Dis Child 1991;66:948-51.
19. Turner DJ, Landau LI, Le Souef PN. The effect of age on bronchodilator responsiveness. Pediatr Pulmonol 1993; 15:98-104.
20. Ho L, Collis G, Landau LI, Le Souef PN. Effect of salbutamol on oxygen saturation in bronchiolitis. Arch Dis Child 1991;66:1061-4.
21. O'Callaghan C, Milner AD, Swarbrick A. Nebulised sodium cromoglycate in infancy: airway protection after deterioration. Arch Dis Child 1990;65:404-6.
22. O'Callaghan C, Milner AD, Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet 1986;ii:1424-5.
23. Thomas RG. Regional human lung dose following inhalation of radioactive particles at ages one month to adulthood. Ann Occup Hyg 1988;32(Suppl 1):1025-33.
24. Xu GB, Yu CP. Effects of age on deposition of inhaled aerosol in the human lung. Aerosol Sci Technol 1986;5: 349-57.
25. Martonen T, Hoffman W. Dosimetry of localised accumulisations of cigarette smoke and radon progeny at bifurcations. Radiat Protect Dosimetry 1991;38:81-9.
26. Everard ML. Studies using radiolabelled aerosols in children. Thorax 1994;49:1259-66.
27. Lipworth BJ. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 1995;50:105-10.
28. Hindel M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992;34:311-5.
29. Vermeire P. European trends in inhalation therapy. Eur Respir Rev 1994;4:89-91.
30. British Thoracic Society, National Asthma Campaign, Royal College of Physicians of London, et al. The British guidelines on asthma management: 1995 review and position statement. Thorax 1997;52(Suppl 2):S1-21.
31. Fergusson RJ, Stewart CM, Wathen CG, Moffat R, Crompton GK. Effectiveness of nebulised salbutamol administered in ambulances to patients with severe acute asthma. Thorax 1995;50:81-2.
32. Robertson C, Smith F, Beck R, Levison H. Response to frequent low doses of nebulised salbutamol in acute asthma. J Paediatr 1984;106:672-4.
33. Schuh S, Parkin P, Rajan A, Canny G, Healy R, Rieder M, et al. High versus low dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics 1989;83:513-8.
34. 2 in children with severe asthma treated with continuously nebulised terbutaline. J Allergy Clin Immunol 1988;81:1101-9.
35. Portnoy J, Aggarwal J. Continuous terbutaline nebulisation for treatment of severe asthma in children. Ann Allergy 1988;60:368-71.
36. Portnoy J, Nadel G, Amado M, Willsie Ediger S. Continuous nebulization for status asthmaticus. Ann Allergy 1992;69:71-9.
37. Katz RW, Kelly W, Crowley MR, Grad R, McWilliams BC, Murphy SJ. Safety of continuous nebulised albuterol for bronchospasm in infants and children. Pediatrics 1993; 92:666-9.
38. Moler FW, Johnson CE, Laanen CV, Palmisano JM, Nasr SZ, Akingbola O. Continuous versus intermittent nebulised terbutaline: plasma levels and effects. Am J Respir Crit Care Med 1995;151:602-6.
39. Singh M, Kumar L. Continuous nebulised salbutamol and oral once a day prednisolone in status asthmaticus. Arch Dis Child 1993;69:416-9.
40. Papo MC, Frank J, Thompson AE. A prospective, randomised study of continuous versus intermittent nebulised albuterol for severe status asthmaticus in children. Crit Care Med 1993;21:1479-86.
41. International Paediatric Asthma Consensus Group. Asthma: a follow up statement from an international paediatric asthma consensus group. Arch Dis Child 1992; 67:240-8.
42. Bentur L, Canny GJ, Shields MD, Kerem E, Schuh S, Reisman JJ, et al. Controlled trial of nebulised albuterol in children younger than 2 years of age with acute asthma. Pediatrics 1992;89:133-7.
43. Hodgson IGC, Groggins RC, Milner AD, Stokes GM. Bronchodilator effects of inhaled ipratropium bromide in wheezy toddlers. Arch Dis Child 1981;56:729-32.
44. Bendefy IM. Home nebulisers in childhood asthma: survey of hospital supervised use. BMJ 1991;302:1180-1.
45. Kisch GL, Paloucek FP. Metered dose inhalers and nebulizers in the acute setting. Ann Pharmacother 1992;26: 92-5.
46. Pierce RJ, McDonald CF, Landau LI, Le Souef PN, Armstrong JG, Mitchell CA. Nebuhaler versus wet aerosol for domiciliary bronchodilator therapy. A multi-centre clinical comparison. Med J Aust 1992;156:771-4.
47. Blackhall MI, O'Donnell SR. A dose response study of inhaled terbutaline administered via Nebuhaler or nebuliser to asthmatic children. Em Respir J 1987;71:96-101.
48. Rivlin J, Mindorff C, Reilly P, Levison H. Pulmonary response to a bronchodilator delivered from three inhalation devices. J Pediatr 1984;104:470-3.
49. Noble V, Ruggins NR, Everard ML, Milner AD. Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child 1992;67:285-8.
50. Connet GJ, Warde C, Wooler E, Lenney W. Use of budesonide in severe asthmatics aged 1-3 years. Arch Dis Child 1993;69:351-5.
51. Fuglsang G, Pedersen S. Comparison of Nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis 1986;69:109-13.
52. Lin YZ, Hsieh KH. Metered dose inhaler and nebuliser in acute asthma. Arch Dis Child 1995;72:2148.
53. Parkin PC, Saunders NR Diamond SA, Winders PM, Macarthur C. Randomised trial spacer v nebuliser for acute asthma. Arch Dis Child 1995;72:239-40.
54. Kerem E, Levison H, Schuh S. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 1993;123:313-7.
55. Vazquez Cordero C, Corera Sanchez M, Molinuevo Alvaro J. Comparison of treatment of acute asthma attacks in children with salbutamol dispensed by the Volumatic dispenser or by a nebulizer. An Esp Pediatr 1992;36: 35-62.
56. Chou KJ, Cunningham SJ, Crain EF. Metered dose inhalers with spacers vs nebulizers for pediatric asthma. Arch Pediatr Adolesc Med 1995;149:201-5.
57. Freelander, Van Asperen. Nebuhaler vs Nebuliser in children with acute asthma. BMJ 1984;288:1873-4.
58. Pendergast J, Hopkins J, Timms B, Van Asperen PP. Comparative efficacy of terbutaline administered by Nebuhaler and by nebulizer in young children with acute asthma. Med J Aust 1989;151:406-8.
59. 2 agonists given via nebuliser, Nebuhaler, or pressurised inhaler by ambulance crew as emergency treatment. Thorax 1995; 50:79-80.
60. Barry PW, Robertson C, O'Callaghan C. Optimum use of a spacer device. Arch Dis Child 1993;69:693-4.
61. Bowton DL, Goldsmith WM, Haponik EF. Substitution of metered dose inhalers for hand held nebulisers: success and cost savings in a large acute care hospital. Chest 1992; 101:305-8.
62. Newhouse MT. Pulmonary drug targeting with aerosols. Am J Asthma Allergy 1993;7:23-35.
63. Godfrey S, Balfour-Lynn L, Konig P. The place of cromolyn sodium in the long term management of childhood asthma based on a 35 year follow up. J Pediatr 1975;87: 465-73.
64. Silverman M, Conolly NM, Balfour-Lynn L, Godfrey S. Long term trial of disodium cromoglycate and isoprenaline in children with asthma. BMJ 1972;3:378-81.
65. Cogswell JJ, Simpkiss MJ. Nebulised sodium cromoglycate in recurrently wheezy preschool children. Arch Dis Child 1985;60:736-8.
66. Bertelsen A, Anderson JB, Busch P, Dangbjerg P, Früs B, Hansen L, et al. Nebulised sodium cromoglycate in the treatment of wheezy bronchitis. Allergy 1986;41:266-70.
67. Henry RL, Hiller EJ, Milner AD, Hodges IGC, Stokes GM. Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life. Arch Dis Child 1984; 59:54-7.
68. Newth CJL, Newth CV, Turner JAP. Comparison of nebulised sodium cromoglycate and oral theophylline in controlling symptoms of chronic asthma in pre-school children: a double blind study. Aust NZ J Med 1982;12: 232-8.
69. Webb MSC, Milner AD, Hiller EJ, Henry RL. Nebulised beclomethasone dipropionate suspension. Arch Dis Child 1986;61:1108-10.
70. Berg E, Bockstrom K, Dahlback M, Nerbrink O. Output and particle size distribution of Pulmicort suspension generated from MAD2 and Pariboy jet nebulisers. J Aerosol Sci 1988;19:1093-6.
71. Godfrey S, Avital A, Rosler A, Mandelberg A, Uwyyed K. Nebulised budesonide in severe infantile asthma. Lancet 1987;ii:851-2.
72. Otulana BA, Varma N, Bullock A, Higenbottam T. High dose nebulised steroid in the treatment of chronic steroid dependent asthma. Respir Med 1992;86:105-8.
73. Llangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner JO. Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension. Arch Dis Child 1993;68:356-9.
74. De Jongste JC, Duiverman EJ. Nebulised budesonide in severe childhood asthma. Lancet 1989;i:1388.
75. Van Bever HP, Schuddinck L, Wojciechowski M, Stevens WJ. Aerosolised budesonide in asthmatic infants. Pediatr Pulmonol 1990;9:177-80.
76. Barry PW, Hocking MD. Paediatric intensive care in the UK. Br J Intensive Care 1995;5:227-32.
77. Ahrens RC, Ries RA, Popendorf W, Wiese. The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol 1986;2:19-26.
78. Garner SS, Wiest DB, Bradley JW. Drug delivery of metered dose inhalers via pediatric endotracheal tubes. Clin Pharm Ther 1993;53:145.
79. Rozycki HJ, Byron PR, Dailey K, Gutcher GR. Evaluation of a system for the delivery of inhaled beclomethasone dipropionate to intubated neonates. Dev Pharmacol Ther 1991;16:65-70.
80. Cameron D, Clay M, Silverman M. Evaluation of nebulisers for use in neonatal ventilator circuits. Crit Care Med 1990;18:866-70.
81. O'Riordan TG, Greco MJ, Perry RJ, Smaldone GC. Nebuliser function during mechanical ventilation. Am Rev Respir Dis 1992;145:1117-22.
82. Thomas SHL, O'Doherry MJ, Fidler HM, Page CJ, Treacher DF, Nunan TO. Pulmonary deposition of a nebulised aerosol during mechanical ventilation. Thorax 1993; 48:154-9.
83. O'Riordan TG, Palmer LB, Smaldone GC. Aerosol deposition in mechanically ventilated patients. Am J Respir Crit Can Med 1994;149:214-9.
84. O'Doherry MJ, Thomas SHL, Page CJ, Treacher DF, Nunan TO. Delivery of a nebulised aerosol to a lung model during mechanical ventilation. Am Rev Respir Dis 1992;146:383-8.
85. Cameron D, Arnot R, Clay M, Silverman M. Aerosol delivery in neonatal ventilator circuits: a rabbit lung model Pediatr Pulmonol 1991;10:208-13.
86. Niven RW, Kacmarek RM, Brain JD, Peterfreund RA. Small bore nozzle extensions to improve the delivery efficiency of drugs from metered dose inhalers: laboratory evaluation. Am Rev Respir Dis 1992;147:1590-4.
87. Dunteman E, Despotis G. A simple method of MDI administration in the intubated patient. Anesth Analg 1992;75:303-13.
88. Taylor RH, Lerman J. High-efficiency delivery of salbutamol with a metered dose inhaler in narrow tracheal tubes and catheters. Anesthesiology 1991;74:360-3.
89. Spahr-Schopfer IA, Lerman J, Cutz E, Newhouse MT, Dolovich M. Proximate delivery of a large experimental dose from salbutamol MDI induces epithelial airway lesions in intubated rabbits. Am J Respir Crit Care Med 1994;150:790-4.
90. Fuller HD, Dolovich MB, Posmituck G, Wong Pack W, Newhouse MT. Pressurised aerosol versus jet aerosol delivery to mechanically ventilated patients. Am Rev Respir Dis 1990;141:440-4.
91. Grigg J, Arnon S, Jones T, Clarke A, Silverman M. Delivery of therapeutic aerosols to intubated babies. Arch Dis Child 1992;67:25-30.
92. O'Callaghan C, Hardy J, Stammers J, Stephenson TJ, Hull D. Evaluation of techniques for delivery of steroids to the lungs of neonates using a rabbit model. Arch Dis Child 1992;67:20-4.
93. Everard ML, Stammers J, Hardy JG, Milner AD. New aerosol delivery system for neonatal ventilator circuits. Arch Dis Child 1992;67:826-30.
94. Arnon S, Grigg J, Nikander K, Silverman M. Delivery of micronised budesonide suspension by metered dose inhaler and jet nebuliser into a neonatal ventilator circuit. Pediatr Pulmonol 1992;13:172-5.
95. Gomez Del Rio M, Gerhardt T, Hehre D, Fuller R, Bancalari E. Effect of beta agonist nebulisation in neonates with increased pulmonary resistance. Pediatr Pulmonol 1986;2:287-91.
96. Motoyama EK, Fort MD, Klesh KW, Mutich RL, Guthrie RS. Early onset of pulmonary reactivity in premature infants with bronchopulmonary dysplasia. Am Rev Respir Dis 1987;136:50-7.
97. Kao LC, Durand DJ, Nickerson BG. Effects of inhaled metaproterenol and atropine on the pulmonary mechanics of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1989;6:74-80.
98. Wilkie RA, Bryan MH. Effects of bronchodilators on airway resistance in ventilator-dependent infants with chronic lung disease. J Pediatr 1987;111:278-82.
99. Yuksel B, Greenhough A. Effect of nebulized salbutamol in preterm infants during the first year of life. Eur Respir J 1991;4:1088-02.
100. Avent ML, Gal P, Ransom JL. The role of inhaled steroids in the treatment of bronchopulmonary dysplasia. Neonatal Network 1994;13:63-9.
101. Davis J, Langenback E, Rohhins C, Sahgal N, Perry R, Simon S. Improved pulmonary distribution of recombinant human superoxide dismutase (rhSOD) using a modified ultrasonic nebuliser. Proceedings of International Neonatal/Infant Aerosol Conference, Boston, USA, 1994.
102. Silverman M. Aerosol therapy in the newborn. Arch Dis Child 1990;65:906-8.
103. Lee H, Arnon S, Silverman M. Bronchodilator aerosol administered by metered dose inhaler and spacer in subacute neonatal respiratory distress syndrome. Arch Dis Child 1994;70:F218-22.
104. Milner AD. Ribavirin and acute bronchiolitis in infancy. BMJ 1988;297:998-9.
105. Barry W, Cockburn F, Cornall R, Price JF, Sutherland G, Vardag A. Ribavirin aerosol for acute bronchiolitis. Arch Dis Child 1986;61:593-7.
106. Hall CB, McBride JT, Walsh EE, Bell DM, Gala CL, Hildreth S, et al. Aerosolised ribavirin treatment of infants with respiratory syncytial viral infection. N Engl J Med 1983;308:1433-7.
107. Navas L, Wang E, Carvalho V, Robison J. Improved outcome of respiratory syncytial virus infection in a high risk hospitalized population of Canadian children. J Pediatr 1992;121:348-54.
108. Groothuis JR, Woodin KA, Katz R, et al. Early ribavirin treatment of respiratory syncytial virus infection in high risk children. J Pediatr 1990;117:792-8.
109. Outwater KM, Meissner HC, Peterson MB. Ribavirin administration to infants receiving mechanical ventilation. Am J Dis Child 1988;142:512-5.
110. Smith DW, Frankel LR, Mathers LH, Tang ATS, Ariagno RL, Prober CG. A controlled trial of aerosolised ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 1991; 325:24-9.
111. Moler FW, Bandy PK, Custer JR. Ribavirin for severe RSV infection. N Engl J Med 1991;325:1884-5.
112. Smith DW, Frankel LR, Mathers LH, Tang ATS, Ariagno RL, Prober CG. Ribavirin for severe RSV infection. N Engl J Med 1991;325:1885.
113. McBride JT, Wooden KA, Katz R. Ribavirin therapy for acute bronchiolitis: the need for appropriate controls. J Pediatr 1991;119:510.
114. Frankel LR, Wilson CW, Demers RR. A technique for the administration of ribavirin to mechanically ventilated infants with severe respiratory syncytial virus infection. Crit Care Med 1987;15:1051-4.
115. Meert KL, Sarnaik AP, Gelmini MJ, Lieh-Lai MW. Aerosolised ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit Care Med 1994;22:566-72.
116. Adderly RJ. Safety of ribavirin with mechanical ventilation. Pediatr Infect Dis J 1990;9:112-4.
117. Rayet I, Teyssier G. Ribavirine et ventilation mecanique. Arch Fr Pediatr 1990;47:467.
118. Englund JA, Piedra PA, Jefferson LS, Wilson SZ, Taber LH, Gilbert BE. High-dose, short duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection. J Pediatr 1990;117:313-20.
119. Wang EEL, Milner R, Allen U, Maj H. Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. Arch Dis Child 1992;67:289-93.
120. Henry RL, Milner AD, Stokes GM. Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch Dis Child 1983;58:925-6.
121. Cressman WR, Myer M. Diagnosis and management of croup and epiglottitis. Pediatr Clin North Am 1994;41: 265-76.
122. McDonogh AJ. The use of steroids and nebulised adrenaline in the treatment of viral croup over a seven year period at a district general hospital. Anaesth Intensive Care 1994;22:175-8.
123. Corneli HM, Bolte RG. Outpatient use of racemic epinephrine in croup. Am Fam Physicianici 1992;46:683-4.
124. Kairys SW, Olmstead EM, O'Connor GT. Steroid treatment in laryngotracheitis: a meta analysis of the evidence from randomised trials. Pediatrics 1989;83:683-93.
125. Husby S, Agertoft L, Mortensen S, Pedersen S. Treatment of croup with nebulised steroid (budesonide): a double blind placebo controlled study. Arch Dis Child 1993;68: 352-5.
126. Sabin AB, Flores AA, De Contro F. Successful immunisation of infants with and without maternal antibody by aerosolised measles vaccine. JAMA 1983;249:2651-62.
127. Whittle UC, Rowland MGM. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine. Lancet 1989;ii:834-7.